Natixis Advisors’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.34M | Buy |
42,508
+2,117
| +5% | +$66.7K | ﹤0.01% | 1210 |
|
2025
Q1 | $1.32M | Buy |
40,391
+1,324
| +3% | +$43.4K | ﹤0.01% | 1200 |
|
2024
Q4 | $1.41M | Sell |
39,067
-251
| -0.6% | -$9.08K | ﹤0.01% | 1203 |
|
2024
Q3 | $1.23M | Buy |
39,318
+5,113
| +15% | +$159K | ﹤0.01% | 1233 |
|
2024
Q2 | $915K | Sell |
34,205
-3,676
| -10% | -$98.3K | ﹤0.01% | 1282 |
|
2024
Q1 | $1.29M | Buy |
37,881
+1,122
| +3% | +$38.3K | ﹤0.01% | 1148 |
|
2023
Q4 | $1.06M | Buy |
36,759
+1,081
| +3% | +$31.3K | ﹤0.01% | 1188 |
|
2023
Q3 | $984K | Buy |
35,678
+1,647
| +5% | +$45.4K | ﹤0.01% | 1179 |
|
2023
Q2 | $1.02M | Sell |
34,031
-2,713
| -7% | -$81.6K | ﹤0.01% | 1151 |
|
2023
Q1 | $1.33M | Buy |
36,744
+1,194
| +3% | +$43.3K | ﹤0.01% | 1067 |
|
2022
Q4 | $1.27M | Buy |
35,550
+755
| +2% | +$26.9K | ﹤0.01% | 1068 |
|
2022
Q3 | $1.18M | Buy |
34,795
+1,497
| +4% | +$50.7K | 0.01% | 1056 |
|
2022
Q2 | $963K | Buy |
33,298
+2,172
| +7% | +$62.8K | ﹤0.01% | 1140 |
|
2022
Q1 | $1.01M | Buy |
31,126
+4,129
| +15% | +$133K | ﹤0.01% | 1132 |
|
2021
Q4 | $787K | Buy |
26,997
+4,953
| +22% | +$144K | ﹤0.01% | 1161 |
|
2021
Q3 | $588K | Buy |
22,044
+2,419
| +12% | +$64.5K | ﹤0.01% | 1186 |
|
2021
Q2 | $604K | Buy |
19,625
+3,525
| +22% | +$108K | ﹤0.01% | 1187 |
|
2021
Q1 | $421K | Sell |
16,100
-96
| -0.6% | -$2.51K | ﹤0.01% | 1190 |
|
2020
Q4 | $407K | Buy |
16,196
+3,774
| +30% | +$94.8K | ﹤0.01% | 1145 |
|
2020
Q3 | $259K | Sell |
12,422
-1,623
| -12% | -$33.8K | ﹤0.01% | 1120 |
|
2020
Q2 | $334K | Buy |
+14,045
| New | +$334K | ﹤0.01% | 1115 |
|
2020
Q1 | – | Sell |
-52,152
| Closed | -$1.24M | – | 1224 |
|
2019
Q4 | $1.24M | Sell |
52,152
-12,793
| -20% | -$303K | 0.01% | 937 |
|
2019
Q3 | $1.79M | Sell |
64,945
-14,932
| -19% | -$410K | 0.01% | 799 |
|
2019
Q2 | $2.64M | Buy |
+79,877
| New | +$2.64M | 0.02% | 686 |
|
2016
Q4 | – | Sell |
-25,746
| Closed | -$637K | – | 1038 |
|
2016
Q3 | $637K | Buy |
25,746
+2,045
| +9% | +$50.6K | 0.01% | 874 |
|
2016
Q2 | $483K | Buy |
+23,701
| New | +$483K | 0.01% | 890 |
|